Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer

被引:57
作者
Srivastava, Amit K. [1 ,11 ]
Banerjee, Ananya [1 ,2 ]
Cui, Tiantian [1 ]
Han, Chunhua [1 ]
Cai, Shurui [1 ]
Liu, Lu [1 ,3 ]
Wu, Dayong [1 ]
Cui, Ri [4 ]
Li, Zaibo [5 ]
Zhang, Xiaoli [6 ]
Xie, Guozhen [1 ]
Selvendiran, Karuppaiyah [7 ]
Patnaik, Srinivas [2 ]
Karpf, Adam R. [8 ]
Liu, Jinsong [9 ]
Cohn, David E. [7 ]
Wang, Qi-En [1 ,10 ]
机构
[1] Ohio State Univ, Coll Med, Dept Radiat Oncol, Columbus, OH 43210 USA
[2] KIIT Deemed Univ, Sch Biotechnol, Bhubaneswar, Odisha, India
[3] Southern Med Univ, Zhujiang Hosp, Oncol Ctr, Guangzhou, Guangdong, Peoples R China
[4] Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Columbus, OH 43210 USA
[5] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA
[6] Ohio State Univ, Coll Med, Ctr Bioinformat, Columbus, OH 43210 USA
[7] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA
[8] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc, Omaha, NE USA
[9] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[10] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA
[11] CSIR, Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India
关键词
MESSENGER-RNA TRANSLATION; ALDEHYDE DEHYDROGENASE; SIGNALING PATHWAYS; OXIDATIVE STRESS; DDB2; PHOSPHORYLATION; ACTIVATION; EXPRESSION; TUMORIGENICITY; RESISTANCE;
D O I
10.1158/0008-5472.CAN-18-3668
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer stem cells (CSC) play a central role in cancer metastasis and development of drug resistance. miRNA are important in regulating CSC properties and are considered potential therapeutic targets. Here we report that miR-328-3p (miR-328) is significantly upregulated in ovarian CSC. High expression of miR-328 maintained CSC properties by directly targeting DNA damage binding protein 2, which has been shown previously to inhibit ovarian CSC. Reduced activity of ERK signaling in ovarian CSC, mainly due to a low level of reactive oxygen species, contributed to the enhanced expression of miR-328 and maintenance of CSC. Inhibition of miR-328 in mouse orthotopic ovarian xenografts impeded tumor growth and prevented tumor metastasis. In summary, our findings provide a novel mechanism underlying maintenance of the CSC population in ovarian cancer and suggest that targeted inhibition of miR-328 could be exploited for the eradication of CSC and aversion of tumor metastasis in ovarian cancer. Significance: These findings present inhibition of miR-328 as a novel strategy for efficient elimination of CSC to prevent tumor metastasis and recurrence in patients with epithelial ovarian cancer.
引用
收藏
页码:2314 / 2326
页数:13
相关论文
共 54 条
[1]   Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells [J].
Baba, T. ;
Convery, P. A. ;
Matsumura, N. ;
Whitaker, R. S. ;
Kondoh, E. ;
Perry, T. ;
Huang, Z. ;
Bentley, R. C. ;
Mori, S. ;
Fujii, S. ;
Marks, J. R. ;
Berchuck, A. ;
Murphy, S. K. .
ONCOGENE, 2009, 28 (02) :209-218
[2]   Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer [J].
Bapat, SA ;
Mali, AM ;
Koppikar, CB ;
Kurrey, NK .
CANCER RESEARCH, 2005, 65 (08) :3025-3029
[3]   Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis [J].
Barakat, Bassant M. ;
Wang, Qi-En ;
Han, Chunhua ;
Milum, Keisha ;
Yin, De-Tao ;
Zhao, Qun ;
Wani, Gulzar ;
Arafa, El-Shaimaa A. ;
El-Mahdy, Mohamed A. ;
Wani, Altaf A. .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (04) :977-988
[4]   Differential activation of ERKs to focal adhesions by PKC ε is required for PMA-induced adhesion and migration of human glioma cells [J].
Besson, A ;
Davy, A ;
Robbins, SM ;
Yong, VW .
ONCOGENE, 2001, 20 (50) :7398-7407
[5]   Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells [J].
Burdon, T ;
Stracey, C ;
Chambers, I ;
Nichols, J ;
Smith, A .
DEVELOPMENTAL BIOLOGY, 1999, 210 (01) :30-43
[6]   High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2-dependent suppression of C/EBPα-driven myeloid differentiation [J].
Chang, Ii Suk ;
Santhanam, Ramasamy ;
Trotta, Rossana ;
Neviani, Paolo ;
Eiring, Anna M. ;
Briercheck, Edward ;
Ronchetti, Mattia ;
Roy, Denis C. ;
Calabretta, Bruno ;
Caligiuri, Michael A. ;
Perrotti, Danilo .
BLOOD, 2007, 110 (03) :994-1003
[7]  
Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
[8]   DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1 [J].
Cui, Tiantian ;
Srivastava, Amit Kumar ;
Han, Chunhua ;
Wu, Dayong ;
Wani, Nissar ;
Liu, Lu ;
Gao, Zhiqin ;
Qu, Meihua ;
Zou, Ning ;
Zhang, Xiaoli ;
Yi, Ping ;
Yu, Jianhua ;
Bell, Erica H. ;
Yang, Shyh-Ming ;
Maloney, David J. ;
Zheng, Yanfang ;
Wani, Altaf A. ;
Wang, Qi-En .
CELL DEATH & DISEASE, 2018, 9
[9]   Tumour stem cells and drug resistance [J].
Dean, M ;
Fojo, T ;
Bates, S .
NATURE REVIEWS CANCER, 2005, 5 (04) :275-284
[10]   MAP kinase signalling pathways in cancer [J].
Dhillon, A. S. ;
Hagan, S. ;
Rath, O. ;
Kolch, W. .
ONCOGENE, 2007, 26 (22) :3279-3290